The U.S. FDA has approved Cinqair – the asthma treatment from Israel’s Teva – for adults who have a history of severe attacks despite taking medication.  More than 22 million Americans had asthma as of 2013, and there are more than 400,000 asthma-related hospitalizations each year.

http://www.reuters.com/article/teva-pharm-ind-fda-idUSL3N16V45V